By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Asuragen, Inc. 

2150 Woodward Street
Suite 100
Austin  Texas  78744  U.S.A.
Phone: 512-651-0191 Fax: 512-721-4859


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





Company News
Asuragen, Inc. To Join Leading UK Cancer Research Consortium To Develop Mirna Based Sequencing Tests For Early Detection And Screening Of Cancer 1/12/2015 11:09:08 AM
Asuragen, Inc. Launches The Quantidex™ DNA Assay To Improve The Accuracy Of Next-Generation Sequencing 11/11/2014 11:10:37 AM
Asuragen, Inc. To Present At Upcoming Association For Molecular Pathology Annual Meeting In National Harbor, MD 11/11/2014 9:38:33 AM
Asuragen, Inc.’s Xpansion Interpreter® Test Study Of 1,040 Transmissions Of Fragile X Alleles Reveals Personalized Risks For Expansion From Parent To Child 9/17/2014 11:03:45 AM
Company Profile For Asuragen, Inc. 8/15/2014 10:44:49 AM
Asuragen, Inc. Names Matthew McManus, M.D., Ph.D., President And CEO 8/5/2014 10:26:29 AM
Asuragen, Inc. Receives New York State License For Molecular Genetic And Oncology Clinical Laboratory Testing 7/10/2014 6:20:01 AM
Asuragen, Inc. Receives Notice of Patent Allowance for Broad Diagnostic Application of miR-21 in Cancer 10/8/2013 10:08:52 AM
Exiqon A/S and Asuragen, Inc. Sign Agreement for Real-Time PCR Services 6/10/2013 9:38:14 AM
Asuragen, Inc. Launches SuraSeq™ Next Generation Sequencing Panel in Its CAP Accredited CLIA Laboratory 5/30/2013 11:04:26 AM
123456789
//-->